274 related articles for article (PubMed ID: 21903747)
21. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
22. Actions of cysteinyl leukotrienes in the enteric nervous system of guinea-pig stomach and small intestine.
Liu S; Hu HZ; Gao C; Gao N; Wang G; Wang X; Gao X; Xia Y; Wood JD
Eur J Pharmacol; 2003 Jan; 459(1):27-39. PubMed ID: 12505531
[TBL] [Abstract][Full Text] [Related]
23. Agonist and antagonist activities of the leukotriene analogue BAY u9773 in guinea pig lung parenchyma.
Wikström Jonsson E; Rosenqvist U; Dahlén SE
Eur J Pharmacol; 1998 Sep; 357(2-3):203-11. PubMed ID: 9797038
[TBL] [Abstract][Full Text] [Related]
24. The cysteinyl-leukotriene receptor antagonist BAY u9773 is a competitive antagonist of leukotriene C4 in the guinea-pig ileum.
Bäck M; Jonsson EW; Dahlén SE
Eur J Pharmacol; 1996 Dec; 317(1):107-13. PubMed ID: 8982726
[TBL] [Abstract][Full Text] [Related]
25. GPR17 is a negative regulator of the cysteinyl leukotriene 1 receptor response to leukotriene D4.
Maekawa A; Balestrieri B; Austen KF; Kanaoka Y
Proc Natl Acad Sci U S A; 2009 Jul; 106(28):11685-90. PubMed ID: 19561298
[TBL] [Abstract][Full Text] [Related]
26. Cysteinyl-leukotrienes receptor activation in brain inflammatory reactions and cerebral edema formation: a role for transcellular biosynthesis of cysteinyl-leukotrienes.
Di Gennaro A; Carnini C; Buccellati C; Ballerio R; Zarini S; Fumagalli F; Viappiani S; Librizzi L; Hernandez A; Murphy RC; Constantin G; De Curtis M; Folco G; Sala A
FASEB J; 2004 May; 18(7):842-4. PubMed ID: 15001558
[TBL] [Abstract][Full Text] [Related]
27. Selectivity of recombinant human leukotriene D(4), leukotriene B(4), and lipoxin A(4) receptors with aspirin-triggered 15-epi-LXA(4) and regulation of vascular and inflammatory responses.
Gronert K; Martinsson-Niskanen T; Ravasi S; Chiang N; Serhan CN
Am J Pathol; 2001 Jan; 158(1):3-9. PubMed ID: 11141472
[TBL] [Abstract][Full Text] [Related]
28. Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis.
Duah E; Teegala LR; Kondeti V; Adapala RK; Keshamouni VG; Kanaoka Y; Austen KF; Thodeti CK; Paruchuri S
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):199-204. PubMed ID: 30559191
[TBL] [Abstract][Full Text] [Related]
29. Antagonist resistant contractions of the porcine pulmonary artery by cysteinyl-leukotrienes.
Bäck M; Norel X; Walch L; Gascard J; Mazmanian G; Dahlén S; Brink C
Eur J Pharmacol; 2000 Aug; 401(3):381-8. PubMed ID: 10936497
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning and functional characterization of murine cysteinyl-leukotriene 1 (CysLT(1)) receptors.
Martin V; Sawyer N; Stocco R; Unett D; Lerner MR; Abramovitz M; Funk CD
Biochem Pharmacol; 2001 Nov; 62(9):1193-200. PubMed ID: 11705452
[TBL] [Abstract][Full Text] [Related]
31. Cysteinyl leukotriene-1 receptor activation in a human bronchial epithelial cell line leads to signal transducer and activator of transcription 1-mediated eosinophil adhesion.
Profita M; Sala A; Bonanno A; Siena L; Ferraro M; Di Giorgi R; Montalbano AM; Albano GD; Gagliardo R; Gjomarkaj M
J Pharmacol Exp Ther; 2008 Jun; 325(3):1024-30. PubMed ID: 18305014
[TBL] [Abstract][Full Text] [Related]
32. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT(2) receptor.
Takasaki J; Kamohara M; Matsumoto M; Saito T; Sugimoto T; Ohishi T; Ishii H; Ota T; Nishikawa T; Kawai Y; Masuho Y; Isogai T; Suzuki Y; Sugano S; Furuichi K
Biochem Biophys Res Commun; 2000 Aug; 274(2):316-22. PubMed ID: 10913337
[TBL] [Abstract][Full Text] [Related]
33. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
Jonsson EW
Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
[TBL] [Abstract][Full Text] [Related]
34. [Method for screening cysteinyl leukotriene receptor 2 antagonists and preliminary screening of compounds].
Cai BL; Huang XQ; Dong XW; Fang SH; Lu YB; Zhang WP; Hu YZ; Shen JG; Wei EQ
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):598-604. PubMed ID: 20014485
[TBL] [Abstract][Full Text] [Related]
35. Human T(H)2 cells respond to cysteinyl leukotrienes through selective expression of cysteinyl leukotriene receptor 1.
Parmentier CN; Fuerst E; McDonald J; Bowen H; Lee TH; Pease JE; Woszczek G; Cousins DJ
J Allergy Clin Immunol; 2012 Apr; 129(4):1136-42. PubMed ID: 22391114
[TBL] [Abstract][Full Text] [Related]
36. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
[TBL] [Abstract][Full Text] [Related]
37. Cysteinyl leukotrienes and their receptors: molecular and functional characteristics.
Singh RK; Gupta S; Dastidar S; Ray A
Pharmacology; 2010; 85(6):336-49. PubMed ID: 20516735
[TBL] [Abstract][Full Text] [Related]
38. Cysteinyl leucotriene receptor type 1 mediates contraction in human and guinea-pig oesophagus.
Chang BS; Chang JC; Wang YS; Huang SC
Neurogastroenterol Motil; 2008 Oct; 20(10):1140-6. PubMed ID: 18651869
[TBL] [Abstract][Full Text] [Related]
39. Regulation of rotenone-induced microglial activation by 5-lipoxygenase and cysteinyl leukotriene receptor 1.
Zhang XY; Chen L; Yang Y; Xu DM; Zhang SR; Li CT; Zheng W; Yu SY; Wei EQ; Zhang LH
Brain Res; 2014 Jul; 1572():59-71. PubMed ID: 24858057
[TBL] [Abstract][Full Text] [Related]
40. Inverse agonist activity of selected ligands of the cysteinyl-leukotriene receptor 1.
Dupré DJ; Le Gouill C; Gingras D; Rola-Pleszczynski M; Stanková J
J Pharmacol Exp Ther; 2004 Apr; 309(1):102-8. PubMed ID: 14718577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
